Julianne Bruno - 23 May 2024 Form 4 Insider Report for CRISPR Therapeutics AG (CRSP)

Role
Chief Operating Officer
Signature
/s/ AJ Silver, attorney-in-fact
Issuer symbol
CRSP
Transactions as of
23 May 2024
Net transactions value
$0
Form type
4
Filing time
24 May 2024, 16:15:54 UTC
Next filing
24 Jun 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CRSP Restricted Stock Units Award $0 +20,000 $0.000000 20,000 23 May 2024 Common Shares 20,000 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares.
F2 This restricted stock unit award was granted on May 23, 2024 with respect to 20,000 Common Shares, with 100% of the shares vesting on May 23, 2026.